Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/naloxone versus buprenorphine for reducing intravenous buprenorphine misuse in France
2009-010360-41Phase 4Completed
- Sponsor
- Reckitt
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine + naloxone and buprenorphine in opioid use disorder (OUD) (2 arms), sponsored by Reckitt. Started Apr 2009; status: completed.
02
Drugs
buprenorphine + naloxonebuprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2009-010360-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010360-41.